Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up
β Scribed by J. F. Graadt van Roggen; J. A. M. van Unnik; I. H. Briaire-de Bruijn; P. C. W. Hogendoorn
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 431 KB
- Volume
- 446
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Bax and Bc12 are functionally antagonistic proteins which control apoptosis, whose expression in human tumours could be of prognostic value. We evaluated Bax and Bcl2 expression in 239 breast carcinomas (99 N0, 140 N1/2) with long term follow-up (median 79 months, range 11-140) in relation to clinic
## BACKGROUND. Controversy exists as to which variable is a reliable predictor of clinical outcome of adrenal cortical tumors in children. ## METHODS. Twenty patients with adrenal cortical tumors were studied. Tumor weight, histologic features, and percentage of proliferating cell nuclear antig
BACKGROUND. p53 is a major tumor suppressor gene that has been implicated in the biology of a variety of human neoplasms, including some that affect the skeleton. Recent studies based on small numbers of cases have shown that overexpression or alteration of the p53 gene is frequently present in high
Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma that has been reported to have a relatively good prognosis. The authors report ten patients with EMC on whom there was a minimum follow-up of 10 years. The patients' ages ranged from 31 to 72 years (mean, 57 years); there were s